Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 5 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 155 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 10 most recent Form 4 transactions.
| ENTX |
| Entera Bio Ltd. |
| AGRANT |
| 19,117 |
| — |
| — |
| +127.5% |
| Open the original filing on SEC.gov |
| Jul 24 | OPK | Opko Health, INC. | FTAX | 53,266 | $1.22 | $65K | -0.8% | Open the original filing on SEC.gov |
| Jun 24 | NAGE | Niagen Bioscience, Inc. | AGRANT◆ | 31,746 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | ELOX | Eloxx Pharmaceuticals,… | AGRANT◆ | 4,018 | — | — | — | Open the original filing on SEC.gov |
| Jun 4 | RDVT | Red Violet, Inc. | AGRANT | 2,179 | — | — | +1.5% | Open the original filing on SEC.gov |
| Jan 24 | ELOX | Eloxx Pharmaceuticals,… | MEXER◆ | 1,875 | — | — | — | Open the original filing on SEC.gov |
| Jan 24 | ELOX | Eloxx Pharmaceuticals,… | MEXER | 1,875 | — | — | +14.7% | Open the original filing on SEC.gov |
| Sep 19, 2025 | ELOX | Eloxx Pharmaceuticals,… | AGRANT◆ | 179,854 | — | — | — | Open the original filing on SEC.gov |